» Articles » PMID: 16998617

In Vitro Chromosome Aberration Tests Using Human Dental Pulp Cells to Detect the Carcinogenic Potential of Chemical Agents

Overview
Journal Odontology
Specialty Dentistry
Date 2006 Sep 26
PMID 16998617
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To examine if human dental pulp cells are useful for assessing the carcinogenic potential of chemical agents, we cultured human dental pulp cells from adults and studied the ability of chemical agents known to be carcinogenic to induce chromosome aberrations in these cells. We confirmed that human dental pulp cells in primary or secondary cultures had the capability of accumulating calcium in vitro as detected by Alizarin red staining and generating dentin-like tissue in immunocompromised mice. These phenotypes were maintained even in cells at seven passages. Next, we examined if chromosome aberrations were induced by exposure of human dental pulp cells (designated here as D824 cells) at seven to nine passages to chemical agents with carcinogenic activity. Statistically significant increases in the frequencies of chromosome aberrations were induced in D824 cells treated with a direct-acting carcinogen, mitomycin C, for 3 h. Chromosome aberrations were also induced at statistically significant levels in D824 cells treated with an indirect-acting carcinogen, cyclophosphamide, for 2 h in the presence of exogenous metabolic activation with rat liver postmitochondrial supernatant. Cyclophosphamide failed to induce chromosome aberrations in the absence of exogenous metabolic activation. Although the reliability of chromosome aberration tests using human dental pulp cells remains to be validated by studying the ability of various other chemical agents with or without carcinogenic activity to induce chromosome aberrations, this chromosome aberration test system may be useful for carcinogenic risk assessment in the target cells.

Citing Articles

Challenge Tooth Regeneration in Adult Dogs with Dental Pulp Stem Cells on 3D-Printed Hydroxyapatite/Polylactic Acid Scaffolds.

Chen R, Hsu S, Chang H, Chen M Cells. 2021; 10(12).

PMID: 34943785 PMC: 8699437. DOI: 10.3390/cells10123277.


Dental Pulp Stem Cells: Advances to Applications.

W Tsutsui T Stem Cells Cloning. 2020; 13:33-42.

PMID: 32104005 PMC: 7025818. DOI: 10.2147/SCCAA.S166759.


CD146 positive human dental pulp stem cells promote regeneration of dentin/pulp-like structures.

Matsui M, Kobayashi T, W Tsutsui T Hum Cell. 2018; 31(2):127-138.

PMID: 29313241 PMC: 5852189. DOI: 10.1007/s13577-017-0198-2.


Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry.

Kobayashi M, W Tsutsui T, Kobayashi T, Ohno M, Higo Y, Inaba T Odontology. 2011; 101(1):43-51.

PMID: 22083529 DOI: 10.1007/s10266-011-0047-9.


Potential feasibility of dental stem cells for regenerative therapies: stem cell transplantation and whole-tooth engineering.

Nakahara T Odontology. 2011; 99(2):105-11.

PMID: 21805289 DOI: 10.1007/s10266-011-0037-y.


References
1.
Benedict W, Banerjee A, Venkatesan N . Cyclophosphamide-induced oncogenic transformation, chromosomal breakage, and sister chromatid exchange following microsomal activation. Cancer Res. 1978; 38(9):2922-4. View

2.
Tsutsui T, Hayashi N, Maizumi H, Huff J, Barrett J . Benzene-, catechol-, hydroquinone- and phenol-induced cell transformation, gene mutations, chromosome aberrations, aneuploidy, sister chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutat Res. 1997; 373(1):113-23. DOI: 10.1016/s0027-5107(96)00196-0. View

3.
Madle S, Westphal D, Hilbig V, Obe G . Testing in vitro of an indirect mutagen (cyclophosphamide) with human leukocyte cultures: Activation by liver perfusion and by incubation with crude liver homogenate. Mutat Res. 1978; 54(1):95-9. DOI: 10.1016/0165-1161(78)90139-5. View

4.
Tsutsui T, Suzuki N, Maizumi H, Barrett J . Comparison of human versus Syrian hamster cells in culture for induction of mitotic inhibition, binucleation and multinucleation, following treatment with four aneuploidogens. Toxicol In Vitro. 2010; 4(1):75-84. DOI: 10.1016/0887-2333(90)90013-j. View

5.
Lomri A, Fromigue O, Hott M, Marie P . Genomic insertion of the SV-40 large T oncogene in normal adult human trabecular osteoblastic cells induces cell growth without loss of the differentiated phenotype. Calcif Tissue Int. 1999; 64(5):394-401. DOI: 10.1007/pl00005821. View